Intra Cellular Therapies | ITCI - EPS - Lucro por Ação


Fiscal Calendário Atual Consenso Anterior Data


Eps Alterar Data
Acadia Pharmaceuticals USD 1.6 1.18 2025-12
ALKERMES USD 0.29 0.2 2025-12
BioCryst Pharmaceuticals USD 1.17 1.1 2025-12
Biogen USD 1.99 2.82 2025-12
Bristol-Myers Squibb USD 1.26 0.37 2025-12
Cytokinetics USD -1.5 1.05 2025-12
Esperion Therapeutics USD 0.26 0.42 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
Halozyme Therapeutics USD -0.24 1.96 2025-12
J&J USD 2.46 0.34 2025-12
Minerva Neurosciences USD -0.56 3.53 2024-12
Nektar Therapeutics USD -1.35 1.17 2025-12
Neurocrine Biosciences USD 1.88 0.29 2025-12
Novartis USD 1.54 0.48 2025-12
Prothena USD -0.46 0.22 2025-12
RedHill Biopharma USD -1.31 33.38 2024-06
Supernus Pharmaceuticals USD -0.07 0.73 2025-12
United Therapeutics USD 7.7 0.54 2025-12
Vanda Pharmaceuticals USD -0.09 0 2024-12